Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Haleon (HLN) has a market cap of $45.67 billion USD. According to our data, Haleon is ranked No.431 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $45.67 B |
5.88%
|
| Dec 31, 2024 | $43.13 B |
17.98%
|
| Dec 29, 2023 | $36.56 B |
4.22%
|
| Dec 30, 2022 | $35.08 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Procter & Gamble
PG
|
$395.04 B |
0.016 M
|
USA
|
 Colgate-Palmolive
CL
|
$76.45 B |
-0.001 M
|
USA
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Unilever
UL
|
$152.68 B |
-0.004 M
|
UK
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
| Market Cap | = | HLN Stock Price | * | HLN Shares Outstanding |
| = | $10.12 | * | 4.51 B | |
| = | $45.67 B |